Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays

Pai, 2008, Review of T-cell-based assays for the diagnosis of latent tuberculosis infection, Ann Intern Med, 149, 1, 10.7326/0003-4819-149-3-200808050-00241 MetaDiSc software, version 1.4: Hospital Ramon y Cajal, Madrid Spain Katiyar, 2008, Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis, Int J Tuber Lung Dis, 2, 1146 Mori, 2004, Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens, Am J Respir Crit Care Med, 170, 59, 10.1164/rccm.200402-179OC Kang, 2007, Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme linked immunospot assay in the diagnosis of active pulmonary tuberculosis, Chest, 132, 959, 10.1378/chest.06-2805 Kobashi, 2006, Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis, Clin Infect Dis, 43, 1540, 10.1086/509327 Ravn, 2005, Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis, Clin Diagn Lab Immunol, 12, 491, 10.1128/CDLI.12.4.491-496.2005 Kobashi, 2008, Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis, Chest, 10.1378/chest.07-1995 Goletti, 2006, Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study, Clin Microbiol Infect, 12, 544, 10.1111/j.1469-0691.2006.01391.x Harada, 2008, Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection, J Infect, 56, 348, 10.1016/j.jinf.2008.02.011 Bartu, 2008, QuantiFERON®-TB Gold in the diagnosis of active tuberculosis, J Int Med Res, 36, 434, 10.1177/147323000803600307 Kobashi, 2008, Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests, Scand J InfectDis, 40, 629, 10.1080/00365540801932454 Kobashi, 2008, Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis, Intern Med, 47, 237, 10.2169/internalmedicine.47.0389 Soysal, 2008, Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection, Int J Tuberc Lung Dis, 12, 50 Nishimura, 2008, Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis, Int J Tuberc Lung Dis, 12, 269 Bua, 2007, QuantiFERON TB Gold: a new method for latent tuberculosis infection, New Microbiol, 30, 477 Kang, 2005, Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country, JAMA, 293, 2756, 10.1001/jama.293.22.2756 Aoki, 2006, Sequential analysis of QuantiFERON-TB Gold test results in active tuberculosis patients: changes in values over time and timing of negative conversion, Kekkaku, 81, 277 Pai, 2007, Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment, Infection, 35, 98, 10.1007/s15010-007-6114-z Ferrara, 2006, Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study, Lancet, 367, 1328, 10.1016/S0140-6736(06)68579-6 Lee, 2006, Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection, Eur Respir J, 28, 24, 10.1183/09031936.06.00016906 Mazurek, 2007, Prospective comparison of the tuberculin skin test and two whole-blood interferon-gamma release assays in persons with suspected tuberculosis, Clin Infect Dis, 45, 837, 10.1086/521107 Dewan, 2007, Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis, Clin Infect Dis, 44, 69, 10.1086/509928 Palazzo, 2008, Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections, Clin Vaccine Immunol, 15, 327, 10.1128/CVI.00342-07 Dominguez, 2008, Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis, Clin Vaccine Immunol, 15, 168, 10.1128/CVI.00364-07 Pai, 2007, Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment, Infection, 35, 98, 10.1007/s15010-007-6114-z Tsiouris, 2006, Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis, J Clin Microbiol, 44, 2844, 10.1128/JCM.02411-05 Adetifa, 2007, Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia, BMC Infect Dis, 7, 122, 10.1186/1471-2334-7-122 Brock, 2001, Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10, Int J Tuberc Lung Dis, 5, 462 Taggart, 2006, Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test, Am J Clin Pathol, 125, 467, 10.1309/LTETF72AHG94KGUY Mazurek, 2007, Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon gamma release assays, Clin Infect Dis, 45, 826, 10.1086/521106 Franken, 2007, Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel, Clin Vaccine Immunol, 14, 477, 10.1128/CVI.00463-06 Soborg, 2007, Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test, Scand J Infect Dis, 39, 554, 10.1080/00365540601148483 Song, 2009, Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis, Diagn Microbiol Infect Dis, 63, 182, 10.1016/j.diagmicrobio.2008.10.013 Ariga, 2007, Diagnosis of active tuberculous serositis by antigen-specific interferon-γ response of cavity fluid cells, Clin Infect Dis, 45, 1559, 10.1086/523591 Diel, 2008, Comparative performance Tuberculin Skin Test, Quantiferon-Gold-in Tube Assay, T-Spot.TB in contact investigations for tuberculosis, Chest Kipfer, 2008, Tuberculosis in a Swiss army training camp: contact investigation using an interferon gamma release assay, Swiss Med Wkly, 138, 267 Funayama, 2005, Usefulness of QuantiFERON-TB-2G in contact investigation of a tuberculosis outbreak in a university, Kekkaku, 80, 527 Fukazawa, 2007, Application and problems of QuantiFERON®TB-2G for tuberculosis control programs. 1. Tuberculosis outbreak in a cram school, Kekkaku, 82, 53 Diel, 2008, Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis, Am J Respir Crit Care Med, 177, 1164, 10.1164/rccm.200711-1613OC Higuchi, 2008, Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis, Tuberculosis (Edinb), 88, 244, 10.1016/j.tube.2007.11.009 Andersen, 2007, The prognosis of latent tuberculosis: can disease be predicted?, Trends Mol Med, 13, 175, 10.1016/j.molmed.2007.03.004 Mazurek, 2005, Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection: United States, MMWR Recomm Rep, 54, 49 National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Clinical Guideline 33, National Collaborating Centre for Chronic Conditions, London March 2006. 2008, Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS), Can Commun Dis Rep, 34, 1 Drobniewski, 2007, Use of gammainterferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006, Euro Surveill, 12 Haute authorite de Sante. Test de detection de la production d’interferon γ pour de diagnostic de infections tuberculeuses. 2006; 1-50, Paris. Lungenliga Schweiz: Handbuch Tuberkulose. 2007. Bern, pp 19-26. 2006, Japanese Society of Tuberculosis. Recommendations for use of QuantiFERON Gold in the diagnosis of tuberculosis infection, Kekkaku, 81, 393 Connell, 2006, Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children, Thorax, 61, 616, 10.1136/thx.2005.048033 Lighter, 2009, Latent tuberculosis diagnosis in children by using the QuantiFERONTB Gold In-Tube Test, Pediatrics, 123, 30, 10.1542/peds.2007-3618 Molicotti, 2008, Performance of QuantiFERON-TB Testing in a tuberculosis outbreak at a primary school, J Pediatr, 152, 585, 10.1016/j.jpeds.2007.12.014 Detjen, 2007, Interferon gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis, Clin Infect Dis, 45, 322, 10.1086/519266 Connell, 2008, A three-way comparison of tuberculin skin testing, QuantiFERONTB Gold and T-SPOT. TB in children, PLoS One, 3, e2624, 10.1371/journal.pone.0002624 Russo, 2007, Agreement between classic diagnostic procedures and the new interferon-gamma release assay for detection of TB disease in children, Rethinking the epidemiology of tuberculosis infection Herrmann, 2009, Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis, PLoS One, 4, 10.1371/journal.pone.0004130 Takamatsu, 2008, Study Group of QFT in Pediatrics. Multicenter study of QuantiFERON in child tuberculosis Dogra, 2007, Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India, J Infect, 54, 267, 10.1016/j.jinf.2006.04.007 Okada, 2008, Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children, Epidemiol Infect, 136, 1179, 10.1017/S0950268807009831 Lewinsohn, 2008, Whole blood interferon-gamma responses to Mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda, PLoS One, 3, e3407, 10.1371/journal.pone.0003407 Connell, 2006, Early detection of perinatal tuberculosis using a whole blood interferon-γ release assay, Clin Infect Dis, 42, 482, 10.1086/503910 Tsiouris, 2006, Results of a tuberculosis-specific IFN-gamma assay in children at high risk of tuberculosis infection, Int J Tuberc Lung Dis, 10, 939 Nakaoka, 2006, Risk for tuberculosis among children, Emerg Infect Dis, 12, 1383, 10.3201/eid1209.051606 Chun JK, Kim CK, Kim HS, Jung GY, et al. The role of a whole blood interferon γ assay for the detection of latent tuberculosis infection in bacille Calmette–Guérin vaccinated children. Diagn Microbiol Infect Dis doi:10.1016/j.diagmicrobio.2008.08.022. Leyten, 2007, Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation, Clin Vacc Immunol, 14, 880, 10.1128/CVI.00132-07 Lewinsohn, 2004, Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities, Int J Tuberc Lung Dis, 8, 658 2000, Targeted tuberculin testing and treatment of latent tuberculosis infection, MMWR, 49, 1 2004, Recommendation for more active use of chemoprophylaxis of tuberculosis (in Japanese), Kekkaku, 79, 747 1981, The tuberculin skin test, Am Rev Respir Dis, 124, 356 Ferrara, 2005, Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection, Am J Respir Crit Care Med, 172, 631, 10.1164/rccm.200502-196OC KobashiY, 2007, Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients, Eur Respir J, 10.1183/09031936.00040007 Mori, 2007, Waning of the specific interferon-gamma response after years of tuberculosis infection, Int J Tuberc Lung Dis, 11, 1021 Raby, 2008, The effects of HIV on the sensitivity of a whole blood IFN-c release assay in Zambian adults with active tuberculosis, PLoS One, 3, e2489, 10.1371/journal.pone.0002489 Vincenti, 2007, Response to region of difference 1 (RD1) epitope in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study, Clin Exp Immunol, 150, 91, 10.1111/j.1365-2249.2007.03462.x Nagai, 2007, Usefulness of a whole blood interferon-gamma assay (QuantiFERON-TB 2G) for detecting tuberculosis infection in HIV-infected persons (in Japanese), Kekkaku, 82, 635 Talati, 2007, Comparison of tuberculin skin test and interferongamma release assays for diagnosis of latent TB infection among HIV positive persons, Rethinking the epidemiology of tuberculosis infection Luetkemeyer, 2007, Comparison of an interferon-{gamma} release assay to tuberculin skin testing in hiv-infected individuals, Am J Respir Crit Care Med, 75, 737, 10.1164/rccm.200608-1088OC Jones, 2007, Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals, Int J Tuberc Lung Dis, 11, 1190 Brock, 2006, Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test, Respir Res, 7, 56, 10.1186/1465-9921-7-56 Stephan, 2008, Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country, AIDS, 22, 2471, 10.1097/QAD.0b013e3283188415 Balcells, 2008, A comparative study of two different methods of the detection of latent tuberculosis in HIV-positive individuals in Chile, Int J Inf Dis, 10.1016/j.ijid.2008.03.005 Hammond, 2008, Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression, J Infect Dis, 197, 295, 10.1086/524685 Hans Rider, 1989, Epidemiology of tuberculosis in the United States, Epidemiol Rev, 11, 79, 10.1093/oxfordjournals.epirev.a036046 Keane, 2001, Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent, N Engl J Med, 345, 1098, 10.1056/NEJMoa011110 Matsumoto, 2006, Infliximab for rheumatoid arthritis in a patient with tuberculosis, New Engl J Med, 355, 740, 10.1056/NEJMc053468 2004, Tuberculosis associated with blocking agents against tumor necrosis factor-alpha – California, 2002–2003, MMWR Morb Mortal Wkly Rep, 53, 683 Matulis, 2008, Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigenspecific interferon gamma assay, Ann Rheum Dis, 67, 84, 10.1136/ard.2007.070789 Chen, 2008, Effectiveness of the Combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy, Arthritis Rheum, 59, 800, 10.1002/art.23705 Schoepfer, 2008, Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease, Am J Gastroenterol, 103, 1, 10.1111/j.1572-0241.2008.02050.x Inamoto, 1987, Tuberculosis in dialysis patients. 3. Epidemiology of pulmonary tuberculosis, Kekkaku, 57, 477 Winthrop, 2008, Interferon-Release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients, Clin J Am Soc Nephrol, 3, 1357, 10.2215/CJN.01010208 Lee, 2008, High Prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test, Infection Ulrichs, 2000, Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy, Int J Tuberc Lung Dis, 4, 1181 Lalvani, 2001, Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians, J Infect Dis, 183, 469, 10.1086/318081 Pathan, 2001, Direct ex vivo analysis of antigen-specific IFN gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment, J Immunol, 167, 5217, 10.4049/jimmunol.167.9.5217 Al-Attiyah, 2003, Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy, FEMS Immunol Med Microbiol, 38, 249, 10.1016/S0928-8244(03)00166-4 Carrara, 2004, Use of a T-cell-based assay for monitoring efficacy of antituberculosis therapy, Clin Infect Dis, 38, 754, 10.1086/381754 Ferrand, 2005, Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment, Int J Tuberc Lung Dis, 9, 1034 Kobashi, 2006, Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis, Clin Infect Dis, 43, 1540, 10.1086/509327 Aiken, 2006, Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases, BMC Infect Dis, 6, 66, 10.1186/1471-2334-6-66 Pai, 2006, Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report, J Occup Med Toxicol, 1, 7, 10.1186/1745-6673-1-7 Wilkinson, 2006, Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens, J Infect Dis, 193, 354, 10.1086/499311 Ewer, 2006, Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis, Am J Respir Crit Care Med, 174, 831, 10.1164/rccm.200511-1783OC Higuchi, 2008, Interferon-γ responses after isoniazid chemotherapy for latent tuberculosis, Respirology, 13, 468, 10.1111/j.1440-1843.2008.01244.x Franken, 2008, Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts, Int J Tuberc Lung Dis, 12, 1286 Dheda, 2007, Interpretation of Mycobacterium tuberculosis antigen-specific IFN-γ release assays (T-SPOT-TB) and factors that may modulate test results, J Infect, 55, 169, 10.1016/j.jinf.2007.02.005